
View larger version (61K):
[in a new window]
|
Fig. 4. (A). HepG2 cells were triple labeled for endogenous Rab18 (red), ADRP (blue), and LDs (green). BODIPY 493/503-stained LDs were labeled for Rab18 and ADRP, but the labeling intensity for Rab18 and ADRP appeared to be reciprocal in most cases. LDs showing strong Rab18 and weak ADRP staining are indicated by arrowheads, and those with the reverse pattern are indicated by arrows. Scale bar: 10 µm. (B) HepG2 cells transfected with EGFP-Rab18(WT) cDNA were labeled with anti-ADRP. Both EGFP-Rab18(WT) (green) and ADRP (red) are visible as small rings of fluorescence, but there is very little overlap. Some Rab18-positive, ADRP-negative ring-shaped fluorescent signals are marked by arrowheads. Scale bar: 10 µm. (C) Western blotting of ADRP. HepG2 cells were transfected with empty vector or Rab18 cDNA. Equal amounts (20 µg) of the total cell lysates were electrophoresed and probed with anti-ADRP antibody. Expression of Rab18 caused a reduction of ADRP. (D) 3T3 cells, expressing EGFP, EGFP-Rab18(WT), EGFP-Rab18(Q67L), or EGFP-Rab18(S22N) (green), were further labeled with anti-ADRP (blue) and Sudan III (red). Merged images of the three colors are shown. EGFP and EGFP-Rab18(S22N) were distributed diffusely in the cytoplasm, and all the Sudan III-positive LDs were labeled with anti-ADRP. In contrast, in cells expressing EGFP-Rab18(WT) or EGFP-Rab18(Q67L), LDs were labeled for either EGFP-Rab18 or ADRP, and those showing both labels were scarce. Scale bar: 10 µm. (E) LDs isolated from HepG2-expressing EGFP-Rab18(WT) (green) were labeled with anti-ADRP (red). LDs with strong EGFP-Rab18(WT) fluorescence generally showed weak ADRP labeling. EGFP-Rab18(WT)-positive, ADRP-negative LDs are indicated by arrowheads. Scale bar: 10 µm.
|